Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol for PTSD in Women Victims of Violence
NCT07792122Phase 3Not yet recruiting
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Sep 2026
- Primary completion
- Mar 2030
- Countries
- 1
01
Overview
A Phase 3 trial of propranolol in post-traumatic stress disorder (PTSD), sponsored by Centre hospitalier universitaire de Toulouse. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
propranolol
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT07792122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07792122.